Article Details
Retrieved on: 2024-08-20 17:07:37
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The biopharmaceutical company is also looking to find a partner for CUE-501, which is being developed to ablate B cells in autoimmune diseases. Recent ...
Article found on: www.investing.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here